Lv1
30 积分 2025-02-27 加入
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
4天前
已完结
In vivo manufacture and manipulation of CAR-T cells for better druggability
4天前
已完结
CAR-T therapy in solid tumors
4天前
已完结
The birth of monoclonal antibodies
4天前
已完结
Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer
14天前
已完结
Expression and prognostic analysis of CLDN18 and Claudin18.2 in lung adenocarcinoma
14天前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
14天前
已完结
A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals
19天前
已完结
The LDL receptor: how acid pulls the trigger
25天前
已完结
Structure of the LDL Receptor Extracellular Domain at Endosomal pH
25天前
已完结
皖公网安备34019202002308
